Literature DB >> 12644578

Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons.

Gabriel A de Erausquin1, Krzyztof Hyrc, David A Dorsey, Daniel Mamah, Mehmet Dokucu, Daniel H Mascó, Timothy Walton, Krikor Dikranian, Mario Soriano, José Manuel García Verdugo, Mark P Goldberg, Laura L Dugan.   

Abstract

We describe a new molecular mechanism of cell death by excitotoxicity mediated through nuclear transcription factor kappa B (NF kappa B) in rat embryonic cultures of dopaminergic neurons. Treatment of mesencephalic cultures with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) resulted in a number of changes that occurred selectively in dopaminergic neurons, including persistent elevation in intracellular Ca(2+) monitored with Fura-2, and a significant increase in intramitochondrial oxidation of dihydrorhodamine 123, probably associated with transient increase of mitochondrial permeability, cytochrome c release, nuclear translocation of NF kappa B, and transcriptional activation of the oncogene p53. Interruption of any of these steps by specific antagonists prevented neurite pruning and programmed cell death. In contrast, cell death was not prevented by caspase antagonists and only partly prevented by nitric-oxide synthase inhibitors. This signal transduction pathway might be a contributing mechanism in ongoing neuronal death in Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644578     DOI: 10.1124/mol.63.4.784

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

Review 2.  Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).

Authors:  Badar Ul Islam; Safia Habib; Parvez Ahmad; Shaziya Allarakha; Asif Ali
Journal:  Indian J Clin Biochem       Date:  2015-01-20

3.  Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population.

Authors:  Danielle Kamis; Lee Stratton; María Calvó; Eduardo Padilla; Néstor Florenzano; Gonzalo Guerrero; Beatriz Molina Rangeon; Juan Molina; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2015-02-27       Impact factor: 4.939

4.  α-Synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity.

Authors:  Huajun Jin; Arthi Kanthasamy; Anamitra Ghosh; Yongjie Yang; Vellareddy Anantharam; Anumantha G Kanthasamy
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

Review 5.  Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases.

Authors:  Heena Khan; Nikhil Garg; Thakur Gurjeet Singh; Amarjot Kaur; Komal Thapa
Journal:  Neurochem Res       Date:  2022-01-04       Impact factor: 3.996

6.  The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells.

Authors:  Victoria Tarabin; Markus Schwaninger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-13       Impact factor: 3.000

7.  Glutamate-induced NFkappaB activation in the retina.

Authors:  Wei Fan; Nigel G F Cooper
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

8.  Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia.

Authors:  Fernando Landreau; Pablo Galeano; Laura R Caltana; Luis Masciotra; Agustín Chertcoff; A Pontoriero; Elsa Baumeister; Marcela Amoroso; Herminia A Brusco; Mónica I Tous; Vilma L Savy; María del Rosario Lores Arnaiz; Gabriel A de Erausquin
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

9.  IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase.

Authors:  Laura L Dugan; Sameh S Ali; Grigoriy Shekhtman; Amanda J Roberts; Jacinta Lucero; Kevin L Quick; M Margarita Behrens
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

10.  The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.

Authors:  S Mustafa; H L Martin; L Burkly; A Costa; M L Martins; M Schwaninger; P Teismann
Journal:  Neuroscience       Date:  2016-01-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.